If you combine resveratrol with lycopene you are bound to have a nutritional supplement with some serious ‘poke’. So it would appear that MedVitál® Bio-Resveratrol®, has something to shout about in the nutraceutical world. Resveratrol is a compound that has been isolated from red grape skins and shown to have specific heart health benefits amongst others. Lycopene is also a powerful nutrient which has benefits as a fat-soluble antioxidant. The rise in diabetes globally means a number of issues arise not least of all the inability for skin lesions such as ulcers to heal themselves. In fact the number of diabetes sufferers is close to 300 million and rising.

A controlled human trial conducted by the Orebro University Hospital and School of Health and Medical Sciences, Orebro, Sweden has compared MedVitál® Bio-Resveratrol® to a placebo. They examined the reduction in foot ulcers in diabetic patients and noticed a significant reduction in their size and painfulness. The new resveratrol mix is a patented form made up of lycopene and trans-resveratrol (t-RSV).

The basics of the study was to take twenty-four subjects, (15 males and 9 females) who were newly diagnosed with diabetic foot ulcers. They were divided into either a placebo or t-RSV-treatment group. Each group was given either the placebo or the lycopene-trans-RSV combination twice a day for 60 days in the same daily dosage as would be sold over the counter in one MedVital® Bio-Resveratrol™ capsule and on top of their regular care and general diabetes treatment.  At the end of the treatment period, the reduction of diabetic ulcer size was almost complete (95%) closure in the t-RSV group. This was significantly better when compared to the placebo (50%).  The t-RSV patients also demonstrated improved performance in the foot pressure test.  The researchers still need to confirm these results and conduct much larger clinical trials.

A comment from one of the researchers in the study, Dr Ivan Petyaev, MD PhD, stated:-

“The Orebro University study has profound implications for the increasing diabetic population that suffers severe and persistent chronic ulceration in the body.”

“For many of these patients, wound control is a primary goal. To date, there is no other treatment approach to this prevalent condition that is the leading cause of lower limb amputation in the world.”

Greg Horn, CEO of Specialty Nutrition Group, Inc., who owns the MedVitál® brand and a commercial partner for the technology reported:-

 “This first trial offers new hope that that diabetic patients suffering from chronic ulceration now have a simple, effective over-the-counter option… as simple as taking a daily nutritional supplement. This alone makes this study truly groundbreaking.”  

MedVitál® Bio-Resveratrol®, is sold at GNC stores across the United States and is the first commercial product to feature this patented and clinically studied form of lycopene and trans-resveratrol.  MedVital® utilizes a proprietary delivery technology that builds natural micelle structures around the resveratrol molecules to enrobe them in lipid coating at the microscopic level for significantly enhanced absorption. In clinical tests, MedVital Bio-Resveratrol was shown to be ten times more bioavailable than regular resveratrol supplements.

References